Edition:
India

Cardiovascular Systems Inc (CSII.OQ)

CSII.OQ on NASDAQ Stock Exchange Global Select Market

34.80USD
1:30am IST
Change (% chg)

$-0.16 (-0.46%)
Prev Close
$34.96
Open
$34.97
Day's High
$34.97
Day's Low
$34.47
Volume
41,338
Avg. Vol
79,459
52-wk High
$35.29
52-wk Low
$20.59

Latest Key Developments (Source: Significant Developments)

Cardiovascular Systems Says OrbusNeich 1.0mm Sapphire II PRO Coronary Balloon Granted FDA Clearance
Friday, 2 Mar 2018 

March 1 (Reuters) - Cardiovascular Systems Inc ::CARDIOVASCULAR SYSTEMS, INC. AND ORBUSNEICH ANNOUNCE FDA CLEARANCE OF THE FIRST AND ONLY 1.0MM CORONARY BALLOON IN THE U.S..CARDIOVASCULAR SYSTEMS INC - ANTICIPATES THAT ORBUSNEICH'S FULL BALLOON PRODUCT PORTFOLIO WILL BECOME AVAILABLE IN U.S. THROUGHOUT 2018 AND 2019.  Full Article

Cardiovascular Systems Appoints Jeff Points As CFO
Thursday, 8 Feb 2018 

Feb 7 (Reuters) - Cardiovascular Systems Inc ::CARDIOVASCULAR SYSTEMS, INC. APPOINTS JEFF POINTS AS CHIEF FINANCIAL OFFICER.CARDIOVASCULAR SYSTEMS INC - ‍POINTS SUCCEEDS LARRY BETTERLEY AS CFO AND WILL REPORT TO SCOTT WARD, CHAIRMAN, PRESIDENT AND CHIEF EXECUTIVE OFFICER​.  Full Article

Cardiovascular Systems Q2 Loss Per Share $0.01
Thursday, 8 Feb 2018 

Feb 7 (Reuters) - Cardiovascular Systems Inc ::CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2018 SECOND-QUARTER FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.01.SEES FY 2018 REVENUE $215 MILLION TO $219 MILLION.Q2 REVENUE ROSE 5 PERCENT TO $52.6 MILLION.SEES Q3 2018 REVENUE $55 MILLION TO $56.5 MILLION.Q2 EARNINGS PER SHARE VIEW $-0.04, REVENUE VIEW $53.4 MILLION -- THOMSON REUTERS I/B/E/S.Q3 REVENUE VIEW $58.6 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Cardiovascular Systems Inc reports Q1 loss per share $0.06
Thursday, 26 Oct 2017 

Oct 25 (Reuters) - Cardiovascular Systems Inc ::Cardiovascular Systems Inc reports fiscal 2018 first-quarter financial results.Q1 loss per share $0.06.Q1 revenue $49.7 million versus I/B/E/S view $51 million.Q1 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S.Sees Q2 2018 loss per share $0.03 to $0.06.Sees FY 2018 revenue $226 million to $233 million.Sees Q2 2018 revenue $52.5 million to $54 million.Q2 earnings per share view $-0.01, revenue view $55.1 million -- Thomson Reuters I/B/E/S.FY2018 revenue view $227.6 million -- Thomson Reuters I/B/E/S.  Full Article

Cardiovascular Systems announces anticipated revenue impact from hurricanes
Monday, 18 Sep 2017 

Sept 18 (Reuters) - Cardiovascular Systems Inc :Cardiovascular Systems announces anticipated revenue impact from hurricanes Harvey and Irma.Cardiovascular Systems - ‍impact of hurricanes Harvey and Irma on procedure volumes in Greater Houstonm Florida will reduce fiscal 2018 Q1 revenues​.Cardiovascular Systems -‍potential revenue impact on CSI quarterly results magnified due to "small product portfolio and location and timing of storms"​.Cardiovascular Systems - ‍fiscal Q1 revenues are more heavily weighted in September, as procedure volumes begin to accelerate from summer levels​.Cardiovascular Systems Inc - ‍"Houston and Florida markets typically generate over 15% of CSI's revenues"​.Cardiovascular Systems - ‍co anticipates that the factors will reduce Q1 revenues below range of $52.6 million to $53.6 million provided on August 2, 2017​.  Full Article

Cardiovascular Systems Q4 earnings per share $0.02
Thursday, 3 Aug 2017 

Aug 2 (Reuters) - Cardiovascular Systems Inc ::Cardiovascular Systems, Inc. Reports fiscal 2017 fourth-quarter financial results.Q4 earnings per share $0.02.Q4 revenue $52.9 million versus I/B/E/S view $52 million.Sees q1 2018 loss per share $0.07 to $0.09.Sees q1 2018 revenue $52.6 million to $53.6 million.Q4 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S.  Full Article

Brown Capital Management LLC reports 7.56 pct passive stake in Cardiovascular Systems
Tuesday, 11 Jul 2017 

July 10 (Reuters) - Cardiovascular Systems Inc :Brown Capital Management LLC reports 7.56 percent passive stake in Cardiovascular Systems Inc as of June 30 - sec filing.  Full Article

Cardiovascular Systems says on June 27, Plaintiffs filed an amended complaint regarding Shoemaker V. Cardiovascular Systems case
Thursday, 29 Jun 2017 

June 29 (Reuters) - Cardiovascular Systems Inc :Cardiovascular Systems - On June 27, 2017, Plaintiffs filed an amended complaint regarding Shoemaker V. Cardiovascular Systems case.Cardiovascular Systems- ‍complaint makes allegations co made materially false, misleading statements,failed to disclose material adverse facts about business.Cardiovascular Systems - Plaintiffs seek unspecified monetary damages on behalf of alleged class, interest, attorney's fees and costs of litigation.Cardiovascular Systems Inc - Complaint relates to ‍alleged kickbacks to health care providers - SEC Filing​.  Full Article

Cardiovascular Systems Q3 loss per share $0.05
Thursday, 4 May 2017 

May 3 (Reuters) - Cardiovascular Systems Inc ::Cardiovascular Systems Inc reports fiscal 2017 third-quarter financial results.Q3 loss per share $0.05.Q3 revenue $52.1 million versus I/B/E/S view $51.1 million.Q3 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S.Sees q4 2017 loss per share $0.04 to $0.06.Sees q4 2017 revenue $51.5 million to $52.5 million.  Full Article

Cardiovascular Systems updates on former employee case
Wednesday, 26 Apr 2017 

April 26 (Reuters) - Cardiovascular Systems Inc :Cardiovascular Systems says jury awarded plaintiff $2.7 million compensatory damages for claims for whistleblower retaliation, wrongful termination.Cardiovascular Systems Inc - Case related to claims made by co's former regional sales manager.Cardiovascular Systems says jury also awarded plaintiff $22.4 million in punitive damages with respect to same claims.Cardiovascular Systems says it is assessing impact of the verdict on its financial results and condition and will provide further updates accordingly.  Full Article

BRIEF-Cardiovascular Systems Inc Q3 Earnings Per Share $0.01

* CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2018 THIRD-QUARTER FINANCIAL RESULTS